Anorectal Dysfunction in Patients Suffering From Spina Bifida : From Clinic to Neuro-epithelial Function (ANOSPIN) (ANOSPIN)

March 27, 2026 updated by: Rennes University Hospital

Anorectal Dysfunction in Patients Suffering From Spina Bifida : From Clinic to Neuro-epithelial Function

The purpose of this study is to assess and explain (at least apart) anorectal disorders of patients with Spina Bifida by an automatic neuropathy responsive of enteric nervous system and epithelial barrier dysfunctions. The investigators' aim hypothetics is that autonomic neuropathy of patients with Spina Bifida induce enteric nervous sytem and epithelial barrier dysfunctions which explain anorectal disorders of these patients. Thexpect to show a decreased of 5% of enteric neurons per ganglia.

Study Overview

Status

Completed

Conditions

Detailed Description

Spina Bifida is rare disease related to a failure of the closure of neural tube during the embryonic period. This malformation results in a variety of clinical disorders (neurologic, urologic, orthopedic, anorectal), depending on the level of the spinal cord lesion. Anorectal functional disorders remain underestimated and unknown from a pathophysiological point of view with subsequent uncodified therapeutic strategy.

Patients with Spina Bifida always present autonomic neuropathy that contributes partially to the anorectal disorders. These disorders may be related to a closed relationship between autonomic and enteric nervous system. Both nervous systems play a key role in anorectal disorders during others neurological disaeses have a common and simultaneous development from neural crest and induce colonic epithelial changes related to the closed connection between epithelial barrier and enteric nervous system. All of this remains hypothetic because no data regarding the impairment of enteric nervous system and epithelial barrier are available and no study are ongoing on this topic.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rennes, France
        • Rennes University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patient aged between 18 and 65 years old
  • patient who consulted to the national Spina Bifida Center for multidisciplinary assessment or for a proctology/urologic clinic
  • need of colonic biopsies during endoscopy
  • free, written and informed consent

Exclusion Criteria:

  • pregnancy or breastfeeding
  • protected adults (judicial protection, guardianship and truesteeship) and persons deprived of liberty
  • patient unable to giving their consent
  • anticoagulants therapy or coagulation disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Enteric nervous system dysfunction
colonic biopsies and usual care
eligible patients will have physical examination, colonic biopsies during endoscopy and anal manometry with barostat. these investigations are part of the usual healthcare. Colonic biopsies will be used to study intestinal permeability, colonic inflammation and enteric nervous system.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of enteric neurons per ganglia
Time Frame: data collected at the day of endoscopy
all data will be collected in the Spina Bifida database for further analyses. Colonic biopsies will be used to study intestinal permeability, colonic inflammation and enteric nervous system
data collected at the day of endoscopy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anorectal symptoms
Time Frame: data collected at the day of endoscopy
data collected at the day of endoscopy
Rectal compliance
Time Frame: data collected at the day of endoscopy
Rectal compliance is defined by a volume variation during ascending pressure (phasic distension). It will be performed with a bag connected to electronic barostat.
data collected at the day of endoscopy
Likert scale
Time Frame: data collected at the day of endoscopy
Sensation intensity will be measured at each pressure step, by using 6-point Likert scale ranging from 0 (no sensation) to 6 (intolerable pain)
data collected at the day of endoscopy
macroscopic and microscopic colonic inflammation
Time Frame: data collected at the day of endoscopy
data collected at the day of endoscopy
intestinal permeability marker
Time Frame: data collected at the day of endoscopy
Intestinal permeability will be measured using Ussing chamber.
data collected at the day of endoscopy
number of glia cells per ganglia
Time Frame: data collected at the day of endoscopy
data collected at the day of endoscopy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Charlène Brochard, Md, Rennes University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2015

Primary Completion (Actual)

May 22, 2017

Study Completion (Actual)

May 22, 2017

Study Registration Dates

First Submitted

April 28, 2015

First Submitted That Met QC Criteria

May 11, 2015

First Posted (Estimated)

May 12, 2015

Study Record Updates

Last Update Posted (Actual)

March 30, 2026

Last Update Submitted That Met QC Criteria

March 27, 2026

Last Verified

March 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spina Bifida

Clinical Trials on Colonic biopsies during endoscopy

Subscribe